Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review
- PMID: 17654125
- DOI: 10.1080/02770900701247178
Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review
Abstract
Inhaled corticosteroids, long-acting beta2-adrenoceptor agonists, and leukotriene receptor antagonists are widely used for treatment of asthma. Inhaled corticosteroids are recommended as first-line therapy, whereas long-acting beta2-adrenoceptor agonists and leukotriene receptor antagonists are indicated as add-on therapy in patients not adequately controlled with corticosteroids alone. A number of studies have investigated the efficacy of combinations of these drugs in asthma, but several issues concerning the safety of these treatments are highly debated. This review provides a critical appraisal of the tolerability profiles of long-acting beta2-agonists and leukotriene receptor antagonists used in combination with inhaled corticosteroids for the treatment of asthma.
Similar articles
-
Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma.Ann Allergy Asthma Immunol. 2009 Jan;102(1):11-5. doi: 10.1016/S1081-1206(10)60101-9. Ann Allergy Asthma Immunol. 2009. PMID: 19205279
-
Complementary therapy in asthma: inhaled corticosteroids and what?Curr Opin Pulm Med. 2009 Jan;15(1):46-51. doi: 10.1097/MCP.0b013e32831da926. Curr Opin Pulm Med. 2009. PMID: 19077705 Review.
-
[Caution recommended in prescribing long-acting beta2-adrenergic agonists to patients with asthma].Ned Tijdschr Geneeskd. 2006 Apr 22;150(16):889-91. Ned Tijdschr Geneeskd. 2006. PMID: 16686087 Dutch.
-
[Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].Ned Tijdschr Geneeskd. 2003 Aug 30;147(35):1681-5. Ned Tijdschr Geneeskd. 2003. PMID: 14513539 Review. Dutch.
-
Balancing safety and efficacy in pediatric asthma management.Pediatrics. 2002 Feb;109(2 Suppl):381-92. Pediatrics. 2002. PMID: 11826254 Review.
Cited by
-
4-CMTB Ameliorates Ovalbumin-Induced Allergic Asthma through FFA2 Activation in Mice.Biomol Ther (Seoul). 2021 Jul 1;29(4):427-433. doi: 10.4062/biomolther.2020.176. Biomol Ther (Seoul). 2021. PMID: 33875623 Free PMC article.
-
The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.Pharmacol Rev. 2019 Jul;71(3):345-382. doi: 10.1124/pr.117.014878. Pharmacol Rev. 2019. PMID: 31235653 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
